First National Bank of Omaha’s West Pharmaceutical WST Stock Holding History

First National Bank of Omaha’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-6,705	Closed	-$500K	–	407
2016 Q3	$500K	Sell	6,705 -5,695	-46%	-$452K	0.04%	271
2016 Q2	$941K	Sell	12,400 -2,550	-17%	-$186K	0.07%	187
2016 Q1	$1.04M	Buy	14,950 +1,025	+7%	+$61.7K	0.08%	181
2015 Q4	$839	Sell	13,925 -625	-4%	-$37.6K	0.06%	203
2015 Q3	$787	Buy	14,550 +25	+0.2%	+$1.46K	0.06%	214
2015 Q2	$774	Hold	14,525	–	–	0.05%	224
2015 Q1	$774	Buy	14,525 +490	+3%	+$26.1K	0.05%	224
2014 Q4	$747K	Buy	14,035 +2,800	+25%	+$140K	0.05%	239
2014 Q3	$503K	Hold	11,235	–	–	0.04%	283
2014 Q2	$474K	Sell	11,235 -775	-6%	-$33.2K	0.03%	304
2014 Q1	$529K	Hold	12,010	–	–	0.04%	285
2013 Q4	$589K	Sell	12,010 -250	-2%	-$11.7K	0.05%	262
2013 Q3	$504K	Sell	12,260 -10,010	-45%	-$382K	0.04%	276
2013 Q2	$782	Buy	+22,270	New	+$733K	0.07%	211

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First National Bank of Omaha's WST Position: Q4 2016 in Review

First National Bank of Omaha sold out of West Pharmaceutical (WST) in Q4 2016, closing a stake of 6,705 shares — an estimated $500K sold.

First National Bank of Omaha first reported a position in WST in Q2 2013 and held it in 14 quarters. The position peaked at $1.04M in Q1 2016. 288 funds tracked by Wall St. Rank hold WST as of Q4 2016.

First National Bank of Omaha reported no remaining West Pharmaceutical position as of Q4 2016 after selling out during the quarter.
First National Bank of Omaha sold 6,705 West Pharmaceutical shares in Q4 2016, an estimated $500K.
First National Bank of Omaha first reported a position in West Pharmaceutical in Q2 2013 and held it in 14 quarters.
First National Bank of Omaha's West Pharmaceutical position peaked at $1.04M in Q1 2016.
288 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2016.

Based on First National Bank of Omaha's 13F filing for Q4 2016, filed 24 Jan 2017.